Navigation Links
Titanium dioxide film enhances the sun's natural disinfection power
Date:1/12/2012

The world population is estimated to be seven billion and all these mouths need feeding. With fears about overfishing and the sustainability of fish stocks in our seas fish farming is becoming big business. As with all farming there are issues about maintaining the health of stock and how to prevent bacterial infection. New research published in BioMed Central's open access journal BMC Microbiology demonstrates that a prototype water purification reactor containing a thin film of titanium dioxide (TiO2) is able to enhance the sun's natural disinfection properties This device could reduce the need for expensive antibiotics or poisonous chemicals.

Outbreaks of infectious diseases by bacteria and other microbial pathogens can cause substantial losses of stock in aquaculture. While antibiotics, biocides and conventional disinfectants can be used, they are expensive and leave behind chemical residues. Using sunlight for disinfection is not a new idea however conventional solar disinfection is slow and inefficient.

Researchers from CQUniversity, Australia, addressed this problem by adapting thin-film fixed-bed reactor (TTFBR) technology to provide treated water. In the reactor water contaminated by Aeromonas hydrophila was slowly passed over a sloping film of TiO2 at a fixed rate and in full sunlight. Results showed that using TiO2 as a photocatalyst increased the effectiveness of solar disinfection by over 10 times.

Prof Rob Reed, one of the team who performed this work explained, "Other people have looked at using TiO2 as an enhancer of solar disinfection, but they either used a suspension of TiO2 particles in water, or artificial UV to test their reactors. Our TTFBR technology is very effective at killing pathogens at high levels of natural sunlight and consequently is particularly suited to countries with sunny climates and is especially useful to developing countries where sunlight is abundant but other resources are scarce."


'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central
Source:Eurekalert

Related biology news :

1. State fund advances titanium powder research, 9 other Iowa State projects
2. Carbon dioxide scrubber captures greenhouse gases
3. Revised theory suggests carbon dioxide levels already in danger zone
4. Engineer to present leak-proof method for carbon dioxide storage at international conference
5. MIT: Safe storage of greenhouse-gas carbon dioxide
6. Carbon dioxide already in danger zone, warns study
7. ESA tests laser to measure atmospheric carbon dioxide
8. Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling
9. NASA-funded carbon dioxide map of US released on Google Earth
10. ISU researcher identifies protein that concentrates carbon dioxide in algae
11. Singapore researchers first to transform carbon dioxide into methanol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology: